These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8106944)

  • 61. [Ovulation induction with human menopausal gonadotropins in hypothalamic-hypophyseal disfunction].
    Ibarra Chavarria V; Mota Gonzalez M; Carballar Lopez G; Espinosa de los Monteros A; Karchmer S
    Ginecol Obstet Mex; 1993 Jul; 61():195-200. PubMed ID: 8349134
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulation.
    Tal J; Paz B; Samberg I; Lazarov N; Sharf M
    Fertil Steril; 1985 Sep; 44(3):342-9. PubMed ID: 3928406
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
    Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
    Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
    Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic value of baseline serum oestradiol in controlled ovarian hyperstimulation of women with unexplained infertility.
    Costello MF; Hughes GJ; Garrett DK; Steigrad SJ; Ekangaki A
    Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):69-74. PubMed ID: 11284650
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
    Wang CF; Gemzell C
    Fertil Steril; 1980 May; 33(5):479-86. PubMed ID: 6768596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical experience in the induction of ovulation and pregnancy with pulsatile subcutaneous administration of human menopausal gonadotropin: a low incidence of multiple pregnancy.
    Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Yoshida K; Tamaoka Y; Suzuki M
    Fertil Steril; 1989 Mar; 51(3):423-9. PubMed ID: 2493402
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
    Kamada S; Kubota T; Aso T
    Horm Res; 1992; 37 Suppl 1():59-63. PubMed ID: 1427631
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Persistent ovarian cysts following administration of human menopausal and chorionic gonadotropins: an attenuated form of ovarian hyperstimulation syndrome.
    Tummon IS; Henig I; Radwanska E; Binor Z; Rawlins R; Dmowski WP
    Fertil Steril; 1988 Feb; 49(2):244-8. PubMed ID: 3123275
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A double-blind, randomized, placebo-controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome.
    Parsanezhad ME; Alborzi S; Pakniat M; Schmidt EH
    Fertil Steril; 2003 Nov; 80(5):1151-5. PubMed ID: 14607566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of various therapies for the luteinized unruptured follicle syndrome.
    Check JH; Dietterich C; Nowroozi K; Wu CH
    Int J Fertil; 1992; 37(1):33-40. PubMed ID: 1348733
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Risks and benefits of gonadotrophin therapy for infertile patients with ovulatory cycles].
    Ishihara O; Ihno Y; Saitoh M; Suno T; Kinoshita K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):221-6. PubMed ID: 8133131
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
    Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
    Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical and endocrine response to pulsatile intravenous gonadotropins in refractory anovulation.
    Yuen BH; Pride SM; Callegari PB; Leroux AM; Moon YS
    Obstet Gynecol; 1989 Nov; 74(5):763-8. PubMed ID: 2510103
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes.
    Kilani Z; Dakkak A; Ghunaim S; Cognigni GE; Tabarelli C; Parmegiani L; Filicori M
    Hum Reprod; 2003 Jun; 18(6):1194-9. PubMed ID: 12773445
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin.
    Eckstein N; Vagman I; Eshel A; Naor Z; Ayalon D
    Fertil Steril; 1985 Dec; 44(6):744-50. PubMed ID: 3935484
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD; Simon JA; Rifka SM; Falk RJ
    Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.